Search

Author/Creator Piplani, Sakshi

1. BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant. Issue 8 (2nd August 2020)

Authors:
Kaushik, Deepender; Dhingra, Simran; Patil, Madhuri T.; Piplani, Sakshi; Khanna, Varun; Honda-Okubo, Yoshikazu; Li, Lei; Fung, Johnson; Sakala, Isaac G.; Salunke, Deepak B.; Petrovsky, Nikolai
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 16:Issue 8(2020)
Page Start:
1989
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant. Issue 8 (2nd August 2020)

Authors:
Kaushik, Deepender; Dhingra, Simran; Patil, Madhuri T.; Piplani, Sakshi; Khanna, Varun; Honda-Okubo, Yoshikazu; Li, Lei; Fung, Johnson; Sakala, Isaac G.; Salunke, Deepak B.; Petrovsky, Nikolai
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 16:Issue 8(2020)
Page Start:
1989
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection. Issue 40 (24th September 2021)

Authors:
Li, Lei; Honda-Okubo, Yoshikazu; Huang, Ying; Jang, Hyesun; Carlock, Michael A.; Baldwin, Jeremy; Piplani, Sakshi; Bebin-Blackwell, Anne G.; Forgacs, David; Sakamoto, Kaori; Stella, Alberto; Turville, Stuart; Chataway, Tim; Colella, Alex; Triccas, Jamie; Ross, Ted M.; Petrovsky, Nikolai
Journal:
Vaccine
Issue:
Volume 39:Issue 40(2021)
Page Start:
5940
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Stereoisomeric Pam2CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants. Issue 5 (28th April 2022)

Authors:
Kaur, Arshpreet; Piplani, Sakshi; Kaushik, Deepender; Fung, Johnson; Sakala, Isaac G.; Honda-Okubo, Yoshikazu; Mehta, Surinder K.; Petrovsky, Nikolai; Salunke, Deepak B.
Journal:
RSC medicinal chemistry
Issue:
Volume 13:Issue 5(2022)
Page Start:
622
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent. (3rd May 2021)

Authors:
Kaushik, Deepender; Granato, Juliana T; Macedo, Gilson C; Dib, Paula R B; Piplani, Sakshi; Fung, Johnson; da Silva, Adilson D; Coimbra, Elaine S; Petrovsky, Nikolai; Salunke, Deepak B
Journal:
Journal of pharmacy and pharmacology
Issue:
Volume 73:Number 9(2021)
Page Start:
1180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent. (3rd May 2021)

Authors:
Kaushik, Deepender; Granato, Juliana T; Macedo, Gilson C; Dib, Paula R B; Piplani, Sakshi; Fung, Johnson; da Silva, Adilson D; Coimbra, Elaine S; Petrovsky, Nikolai; Salunke, Deepak B
Journal:
Journal of pharmacy and pharmacology
Issue:
Volume 73:Number 9(2021)
Page Start:
1180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗